Breaking News

Earlier this month, Locus entered into an exclusive collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. The agreement, facilitated by Johnson & Johnson Innovation, includes an initial investment of $20 million and is potentially worth up to $818 million. The partnership is focused on the development and manufacturing of CRISPR-Cas3-enhanced bacteriophage products targeting two key bacterial pathogens of the respiratory tract and other organ systems. After the deal, Locus will retain all rights to the technology and its application to other pathogens.

LEARN MORE

Research Commercialization News

NIRvana Sciences Awarded $3 Million Phase IIb SBIR Grant from NIH

NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins, today announced that it has been awarded a $3 Million Phase IIb SBIR grant from the National Institute of Allergy and Infectious Diseases (NIAID)...

Continue reading "NIRvana Sciences Awarded $3 Million Phase IIb SBIR Grant from NIH"

NC State Spinout Locus Biosciences Inks Historic Licensing Deal

NC State provides innovators with a range of programs and services to develop, protect, market and commercialize inventions developed at the university through the licensing of intellectual property or the launch of new companies based...

Continue reading "NC State Spinout Locus Biosciences Inks Historic Licensing Deal"

Howling Cow Ice Cream Available in Harris Teeter Stores

A State Fair and NC State campus delectable treat is now available for the first time in grocery retail locations across parts of the Triangle. Six different flavors of Howling Cow® ice cream can be purchased...

Continue reading "Howling Cow Ice Cream Available in Harris Teeter Stores"

View More Research Commercialization News

NSF ICorps Logo

NC State’s I-Corps Program

Are you interested in learning more about how your research would fit into the marketplace? NC State’s I-Corps Site provides training and funding to help you better understand how your solution fits in the marketplace and improve the prospects of attracting funding.


Take a look! @NCState Research Commercialization FY18 Statistics https://t.co/wiWKDvmMbB
h J R
Congrats to @NCState #startup founder Rodolphe Barrangou for being elected to National Academy of Engineering! https://t.co/Ju5QJNhOLt
h J R
RT @NCSTI: Congrats to @NCCommerce #OneNCSmallBiz grantee & @NCState #spinout, Nirvana Sciences (@NIRvanaScience) on their recent PII @NIH
h J R
RT @piercelab: We're working to commercialize our antibiotic discovery projects in collaboration with Synoxa Sciences, Inc (@SynoxaS), a di…
h J R

1010+
Patents Issued

141+
New License and Option Agreements

135+
Startups Launched

3,600+
Jobs Created in North Carolina

$1.7B+
in Financing Raised by
NC State Startups

595+
Products to Market

Research Commercialization Events

View Detailed List with Links | View on Google Calendar